Andrea Weiss, BS, R.Ph

CRS:

JHU

Role:

Pharmacy

Position:

Pharmacist of Record

Email:

aweiss@jhmi.edu
  • Member, Protocol Development and Implementation Subcommittee of the SMCCC (Dec 2015)
  • Member, Pharmacy Working Group of the PDIC (Feb 2015)
  • Member, Site Pharmacist Working Group of the Pharmacy Subcommittee (Feb 2015)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

NWCS 408: Examining Longitudinal Cytokine Profiles in HIV-TB...

Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...

Read More

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

A5324: A Randomized, Double-Blinded, Placebo-Controlled...

ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...

Read More

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

Read More